Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of 89bio Inc (NASDAQ: ETNB) was $10.49 for the day, down -1.50% from the previous closing price of $10.65. In other words, the price has decreased by -$1.50 from its previous closing price. On the day, 1.31 million shares were traded. ETNB stock price reached its highest trading level at $10.81 during the session, while it also had its lowest trading level at $10.38.
Ratios:
Our analysis of ETNB’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 18.03 and its Current Ratio is at 18.03. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on March 14, 2025, initiated with a Neutral rating and assigned the stock a target price of $11.
On March 13, 2025, Citigroup started tracking the stock assigning a Buy rating and target price of $25.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 15 ’25 when Le-Nguyen Quoc sold 10,461 shares for $11.02 per share. The transaction valued at 115,280 led to the insider holds 309,364 shares of the business.
QUOC LE-NGUYEN bought 10,461 shares of ETNB for $115,233 on Jul 15 ’25. On Apr 15 ’25, another insider, Le-Nguyen Quoc, who serves as the insider of the company, sold 15,329 shares for $5.95 each. As a result, the insider received 91,208 and left with 328,323 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ETNB now has a Market Capitalization of 1531372160 and an Enterprise Value of 832363648.
Stock Price History:
The Beta on a monthly basis for ETNB is 1.36, which has changed by 0.2623346 over the last 52 weeks, in comparison to a change of 0.13161862 over the same period for the S&P500. Over the past 52 weeks, ETNB has reached a high of $11.84, while it has fallen to a 52-week low of $4.16. The 50-Day Moving Average of the stock is 8.62%, while the 200-Day Moving Average is calculated to be 22.82%.
Shares Statistics:
ETNB traded an average of 1.91M shares per day over the past three months and 1220030 shares per day over the past ten days. A total of 145.98M shares are outstanding, with a floating share count of 141.32M. Insiders hold about 3.20% of the company’s shares, while institutions hold 107.36% stake in the company. Shares short for ETNB as of 1749772800 were 13985891 with a Short Ratio of 8.29, compared to 1747267200 on 15478047. Therefore, it implies a Short% of Shares Outstanding of 13985891 and a Short% of Float of 13.340001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Currently, 7.0 analysts are dedicated to thoroughly evaluating and rating the performance of 89bio Inc (ETNB) in the stock market.The consensus estimate for the next quarter is -$0.52, with high estimates of -$0.4 and low estimates of -$0.62.
Analysts are recommending an EPS of between -$1.74 and -$2.36 for the fiscal current year, implying an average EPS of -$2.11. EPS for the following year is -$2.26, with 9.0 analysts recommending between -$1.25 and -$2.87.
